MENOPAUSE
Vaginal Dryness and Menopause
Why vaginal dryness during menopause deserves clinical attention, what treatment options exist, and when confidential assessment is worth arranging.
Vaginal dryness is one of the most common symptoms of perimenopause and menopause, yet it remains one of the least discussed. Many women delay seeking advice — either because they consider it a normal part of ageing, because they find the topic difficult to raise, or because they assume little can be done. In practice, effective treatments exist, and most women benefit significantly from a straightforward clinical conversation.
Symptoms may include vaginal dryness, soreness, irritation, discomfort during sex, reduced lubrication, a sense that tissues feel more fragile than before, and recurrent urinary irritation or urgency. Unlike hot flushes and night sweats, which may improve over time, vaginal symptoms typically persist or worsen without treatment. For the broader menopause overview, see menopause and HRT.
ON THIS PAGE
Why it happens
Declining oestrogen levels during menopause affect the vaginal mucosa, reducing moisture, elasticity and blood flow to vaginal and vulval tissues. The medical term — genitourinary syndrome of menopause (GSM) — reflects the fact that these changes can affect the vagina, vulva, bladder and urethra. Symptoms may begin during perimenopause and tend to progress if untreated. Some women notice changes gradually; others find the onset more abrupt, particularly after surgical menopause or cessation of HRT.
Why assessment matters
Vaginal dryness is not always menopausal. The clinical picture can overlap with infection, dermatological conditions, medication side effects, or reduced oestrogen from other causes. A consultation can help determine the most likely explanation, establish whether symptoms form part of a broader menopausal pattern, and identify the right treatment. Where other symptoms such as night sweats, mood change, or cycle disruption are also present, broader menopause assessment may be relevant.
Treatment
Treatment options worth discussing
Localised vaginal oestrogen — available as pessaries, cream or a ring — is well established, effective, and considered low-risk for most women, including many who cannot take systemic HRT. It works directly on vaginal and urinary tissues without significant systemic absorption. Systemic HRT may also address vaginal symptoms alongside broader menopausal symptoms such as flushes, sweats, mood disturbance and sleep disruption.
Non-hormonal moisturisers and lubricants can provide additional comfort and may be sufficient for mild symptoms. Your GP can discuss which combination is most appropriate given your wider clinical picture and treatment preferences.
Same-day appointments available. Book online or call 020 7736 7557.
Discussing intimate symptoms in a private setting
Many women find it easier to discuss intimate symptoms in a private practice where the consultation is unhurried, confidential, and conducted by a GP who has time to listen properly. At Basuto, appointments are 30 minutes, giving time to cover symptoms thoroughly, explain treatment options clearly, and agree on a plan. If you would prefer a remote first step, an online appointment may also be useful for discussing symptoms and treatment options before attending in person.
Wider care
When vaginal symptoms sit alongside other changes
Vaginal dryness often coexists with other menopausal symptoms — hot flushes, sleep disruption, mood change, reduced libido, fatigue or urinary urgency. Where multiple symptoms are present, broader women’s health assessment may be the most useful starting point. Systemic HRT can address both vaginal and vasomotor symptoms simultaneously.
Where vaginal dryness is the primary or only concern, localised treatment alone may be sufficient. Your GP can help determine which approach suits your situation and arrange any relevant blood tests or referrals from the same consultation.
Frequently asked questions
Is vaginal dryness always related to menopause?
Not always. Other causes can include medication side effects (particularly antihistamines, antidepressants and some contraceptives), skin conditions, infection, breastfeeding, or reduced oestrogen from other medical causes. Assessment helps determine the most likely explanation and the most appropriate treatment.
Does localised oestrogen carry the same risks as systemic HRT?
No. Localised vaginal oestrogen is absorbed minimally into the bloodstream and is considered safe for the vast majority of women, including many who cannot take systemic HRT. Current guidance supports its long-term use where symptoms require it. Individual suitability depends on medical history, which is assessed during the consultation.
Can this be discussed in an online appointment?
Yes. An online appointment can be a practical first step to discuss symptoms and treatment options confidentially, particularly if you would find this more comfortable than attending in person initially. Prescriptions can be issued following a video consultation where clinically appropriate.
FURTHER READING